Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 TCR α/β Complementarity Determining Region Residues Identified from gp100154–162 specific CD8+ T cell clones

From: Use of high throughput qPCR screening to rapidly clone low frequency tumour specific T-cells from peripheral blood for adoptive immunotherapy

   α-CDR1   α-CDR2    α-CDR3  
  TRAV                           
Patient 2 12.1 N S A S Q S   V Y S S G    V V N M N S N Y Q L I  
Patient 5 8.1 Y G G T V N   Y F S G D P L   A V N G D D K I I   
Patient 6 5 D S S S T Y   I F S N M D   A E M A N S G Y A L N  
Patient 7 5 D S S S T Y   I F S N M D   A E N P E G N D M R   
   β-CDR1   β-CDR2   β-CDR3    
  TRBV                           
Patient 2 15 L N H N V   Y Y D K D F   A T S Q E A S F T D T Q Y
Patient 5 7.6 S G H V S   F N Y E A Q   A S S L G G G Q D T Q Y  
Patient 6 12.3 S G H N S   F N N N V P   A S S P G G G E Q F    
Patient 7 11.2 S G H A T   F Q N N G V   A S S P G G G G E Q F